Puma Biotechnology
PBYI
PBYI
110 hedge funds and large institutions have $948M invested in Puma Biotechnology in 2016 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 28 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
29% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 28
43% less call options, than puts
Call options by funds: $3.89M | Put options by funds: $6.8M
Holders
110
Holding in Top 10
–
Calls
$3.89M
Puts
$6.8M
Top Buyers
| 1 | +$43.8M | |
| 2 | +$17.7M | |
| 3 | +$17.5M | |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
+$13.4M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$11.1M |
Top Sellers
| 1 | -$59.1M | |
| 2 | -$24.7M | |
| 3 | -$20.5M | |
| 4 |
VAM
Visium Asset Management
New York
|
-$6.34M |
| 5 |
CCM
Cornerstone Capital Management
Edina,
Minnesota
|
-$3.77M |